Disease - Clinical trilas for the 333 intractable diseases designated by the Ministry of Health, Labour and Welfare (MHLW), Japan💬 Info on mouse-over
ID | Disease name | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients (1) MHLW, (2) Med expenses recipients (FY2020) | Related info (in Japanese) |
1 | Spinal and bulbar muscular atrophy "Spinobulbar muscular atrophy", "SBMA", "Kennedy disease", "Kennedy-Alter-Sung syndrome" | 17 17 trials 0 / 9 / 2 / 1 💬 | 16 16 drugs [ 8 8 drugs ] | 10 10 genes 15 pathways | (1) 1,223 patients (2) 1,622 patients Age distribution ![]() | Biobank Animal model |
2 | Amyotrophic lateral sclerosis "ALS" | 508 508 trials 252 / 235 / 151 / 35 💬 | 530 530 drugs [ 146 146 drugs ] | 170 170 genes 221 pathways | (1) 9,096 patients (2) 10,514 patients Age distribution ![]() | Biobank Animal model |
3 | Spinal muscular atrophy "Myelopathic muscular atrophy", "SMA I", "Werdnig-Hoffman disease", "SMA II", "Dubowitz disease", "SMA III", "Kugelberg-Welander disease", "SMA IV" | 179 179 trials 141 / 107 / 75 / 28 💬 | 102 102 drugs [ 26 26 drugs ] | 52 52 genes 78 pathways | (1) 712 patients (2) 921 patients Age distribution ![]() | Biobank Pediatric diseases |
4 | Primary lateral sclerosis "PLS" | 6 6 trials 3 / 2 / 0 / 1 💬 | 16 16 drugs [ 8 8 drugs ] | 19 19 genes 32 pathways | (1) 175 patients (By the research group) (2) 127 patients Age distribution ![]() | Biobank |
5 | Progressive supranuclear palsy "PSP" | 82 82 trials 48 / 35 / 12 / 6 💬 | 107 107 drugs [ 36 36 drugs ] | 60 60 genes 90 pathways | (1) About 8,100 patients (2) 12,766 patients Age distribution ![]() | Biobank |
6 | Parkinson disease | 2,123 2,123 trials 864 / 632 / 514 / 272 💬 | 2,046 2,046 drugs [ 324 324 drugs ] | 183 183 genes 198 pathways | (1) About 108,800 patients (estimated from Parkinson disease related diseases) (2) 142,375 patients Age distribution ![]() | Biobank |
7 | Corticobasal degeneration "Corticobasal syndrome", "CBD" | 16 16 trials 5 / 2 / 1 / 0 💬 | 33 33 drugs [ 11 11 drugs ] | 6 6 genes 13 pathways | (1) 3,500 patients (2) 4,749 patients Age distribution ![]() | |
8 | Huntington disease "Huntington chorea" | 197 197 trials 127 / 103 / 42 / 20 💬 | 171 171 drugs [ 54 54 drugs ] | 82 82 genes 144 pathways | (1) 933 patients (2) 950 patients Age distribution ![]() | Biobank Animal model |
9 | Neuroacanthocytosis "Choreoacanthocytosis", "Chorea-acanthocytosis", "Levine-Critchley syndrome", "McLeod syndrome", "Huntington disease-like 2", "HDL2", "Pantothenate kinase-associated neurodegeneration", "PKAN", "Hallervorden-Spatz syndrome" collapse"Choreoacanthocytosis", "Chorea-acanthocytosis", "Levine-Critchley syndrome", "McLeod syndrome", "Huntington disease-like 2", "HDL2", "Pantothenate ki ... show all | 0 - | 0 - | 0 - | (1) Less than 100 patients (By the research group) (2) 33 patients Age distribution ![]() | Pediatric diseases |
10 | Charcot-Marie-Tooth disease "CMT" | 31 31 trials 23 / 16 / 16 / 4 💬 | 38 38 drugs [ 9 9 drugs ] | 11 11 genes 14 pathways | (1) 6,250 patients (By the research group) (2) 774 patients Age distribution ![]() | Biobank Animal model Pediatric diseases |